153 related articles for article (PubMed ID: 38778378)
1. Causal roles and clinical utility of cardiovascular proteins in colorectal cancer risk: a multi-modal study integrating mendelian randomization, expression profiling, and survival analysis.
Tan C; Li Y; Wang K; Lin Y; Chen Y; Zheng X
BMC Med Genomics; 2024 May; 17(1):138. PubMed ID: 38778378
[TBL] [Abstract][Full Text] [Related]
2. Potential drug targets for tumors identified through Mendelian randomization analysis.
Song N; Shi P; Cui K; Zeng L; Wang Z; Di W; Li J; Fan Y; Li Z; Zhang J; Su W; Wang H
Sci Rep; 2024 May; 14(1):11370. PubMed ID: 38762700
[TBL] [Abstract][Full Text] [Related]
3. Integrated multi-omics analyses revealed the association between rheumatoid arthritis and colorectal cancer: MYO9A as a shared gene signature and an immune-related therapeutic target.
Zhan ZQ; Huang ZM; Lan QW; Luo YH; Li JX; Zheng YF; Chen YZ; Chen PZ; Luo TY; Sun B; Cheng ZJ
BMC Cancer; 2024 Jun; 24(1):714. PubMed ID: 38858644
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating human plasma proteome with genome.
Sun J; Zhao J; Jiang F; Wang L; Xiao Q; Han F; Chen J; Yuan S; Wei J; Larsson SC; Zhang H; Dunlop MG; Farrington SM; Ding K; Theodoratou E; Li X
Genome Med; 2023 Sep; 15(1):75. PubMed ID: 37726845
[TBL] [Abstract][Full Text] [Related]
5. Mendelian randomization and genetic colocalization infer the effects of the multi-tissue proteome on 211 complex disease-related phenotypes.
Yang C; Fagan AM; Perrin RJ; Rhinn H; Harari O; Cruchaga C
Genome Med; 2022 Dec; 14(1):140. PubMed ID: 36510323
[TBL] [Abstract][Full Text] [Related]
6. Proteome-wide Mendelian randomization identifies potential therapeutic targets for nonalcoholic fatty liver diseases.
Li J; Ma X; Yin C
Sci Rep; 2024 May; 14(1):11814. PubMed ID: 38782984
[TBL] [Abstract][Full Text] [Related]
7. Causal associations between liver traits and Colorectal cancer: a Mendelian randomization study.
Ni Y; Wang W; Liu Y; Jiang Y
BMC Med Genomics; 2023 Dec; 16(1):316. PubMed ID: 38057864
[TBL] [Abstract][Full Text] [Related]
8. Prioritizing putative influential genes in cardiovascular disease susceptibility by applying tissue-specific Mendelian randomization.
Taylor K; Davey Smith G; Relton CL; Gaunt TR; Richardson TG
Genome Med; 2019 Jan; 11(1):6. PubMed ID: 30704512
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association studies and Mendelian randomization analyses provide insights into the causes of early-onset colorectal cancer.
Laskar RS; Qu C; Huyghe JR; Harrison T; Hayes RB; Cao Y; Campbell PT; Steinfelder R; Talukdar FR; Brenner H; Ogino S; Brendt S; Bishop DT; Buchanan DD; Chan AT; Cotterchio M; Gruber SB; Gsur A; van Guelpen B; Jenkins MA; Keku TO; Lynch BM; Le Marchand L; Martin RM; McCarthy K; Moreno V; Pearlman R; Song M; Tsilidis KK; Vodička P; Woods MO; Wu K; Hsu L; Gunter MJ; Peters U; Murphy N;
Ann Oncol; 2024 Jun; 35(6):523-536. PubMed ID: 38408508
[TBL] [Abstract][Full Text] [Related]
10. Genetically determined circulating resistin concentrations and risk of colorectal cancer: a two-sample Mendelian randomization study.
Pham TT; Nimptsch K; Papadimitriou N; Aleksandrova K; Jenab M; Gunter MJ; Le Marchand L; Li L; Lynch BM; Castellví-Bel S; Phipps AI; Schmit SL; Brenner H; Ogino S; Giovannucci E; Pischon T
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14889-14900. PubMed ID: 37599317
[TBL] [Abstract][Full Text] [Related]
11. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
Henry A; Gordillo-Marañón M; Finan C; Schmidt AF; Ferreira JP; Karra R; Sundström J; Lind L; Ärnlöv J; Zannad F; Mälarstig A; Hingorani AD; Lumbers RT;
Circulation; 2022 Apr; 145(16):1205-1217. PubMed ID: 35300523
[TBL] [Abstract][Full Text] [Related]
13. Genetic associations in ankylosing spondylitis: circulating proteins as drug targets and biomarkers.
Zhang Y; Liu W; Lai J; Zeng H
Front Immunol; 2024; 15():1394438. PubMed ID: 38835753
[TBL] [Abstract][Full Text] [Related]
14. Mendelian randomization analysis identifies druggable genes and drugs repurposing for chronic obstructive pulmonary disease.
Wang Z; Li S; Cai G; Gao Y; Yang H; Li Y; Liang J; Zhang S; Hu J; Zheng J
Front Cell Infect Microbiol; 2024; 14():1386506. PubMed ID: 38660492
[TBL] [Abstract][Full Text] [Related]
15. Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
Nimptsch K; Aleksandrova K; Pham TT; Papadimitriou N; Janke J; Christakoudi S; Heath A; Olsen A; Tjønneland A; Schulze MB; Katzke V; Kaaks R; van Guelpen B; Harbs J; Palli D; Macciotta A; Pasanisi F; Yohar SMC; Guevara M; Amiano P; Grioni S; Jakszyn PG; Figueiredo JC; Samadder NJ; Li CI; Moreno V; Potter JD; Schoen RE; Um CY; Weiderpass E; Jenab M; Gunter MJ; Pischon T
BMC Med; 2023 Oct; 21(1):391. PubMed ID: 37833736
[TBL] [Abstract][Full Text] [Related]
16. Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer.
Zhou S; Tao B; Guo Y; Gu J; Li H; Zou C; Tang S; Jiang S; Fu D; Li J
J Transl Med; 2024 Jun; 22(1):557. PubMed ID: 38858729
[TBL] [Abstract][Full Text] [Related]
17. Proteome-wide analysis reveals potential therapeutic targets for Colorectal cancer: a two-sample mendelian randomization study.
Cai YX; Wu YQ; Liu J; Pan H; Deng W; Sun W; Xie C; Huang XF
BMC Cancer; 2023 Dec; 23(1):1188. PubMed ID: 38049731
[TBL] [Abstract][Full Text] [Related]
18. A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer.
Nounu A; Greenhough A; Heesom KJ; Richmond RC; Zheng J; Weinstein SJ; Albanes D; Baron JA; Hopper JL; Figueiredo JC; Newcomb PA; Lindor NM; Casey G; Platz EA; Le Marchand L; Ulrich CM; Li CI; van Duijnhoven FJB; Gsur A; Campbell PT; Moreno V; Vodicka P; Vodickova L; Brenner H; Chang-Claude J; Hoffmeister M; Sakoda LC; Slattery ML; Schoen RE; Gunter MJ; Castellví-Bel S; Kim HR; Kweon SS; Chan AT; Li L; Zheng W; Bishop DT; Buchanan DD; Giles GG; Gruber SB; Rennert G; Stadler ZK; Harrison TA; Lin Y; Keku TO; Woods MO; Schafmayer C; Van Guelpen B; Gallinger S; Hampel H; Berndt SI; Pharoah PDP; Lindblom A; Wolk A; Wu AH; White E; Peters U; Drew DA; Scherer D; Bermejo JL; Williams AC; Relton CL
Cancer Epidemiol Biomarkers Prev; 2021 Mar; 30(3):564-575. PubMed ID: 33318029
[TBL] [Abstract][Full Text] [Related]
19. Causal effect of gut microbiota on pancreatic cancer: A Mendelian randomization and colocalization study.
Li X; Liang Z
J Cell Mol Med; 2024 Apr; 28(8):e18255. PubMed ID: 38526030
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction.
Sun Z; Yun Z; Lin J; Sun X; Wang Q; Duan J; Li C; Zhang X; Xu S; Wang Z; Xiong X; Yao K
J Transl Med; 2024 Apr; 22(1):404. PubMed ID: 38689297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
